Shuttle Pharmaceuticals Holdings, Inc.
SHPHNasdaqCIK 1757499HealthcareFiscal year ends Dec 31
Reports and events: 147 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2220:30 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001493152-26-048112 |
| 2026-09-2416:01 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001493152-26-044107 |
| 2026-09-2416:00 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001493152-26-044106 |
| 2026-09-1622:15 ET | 8-K | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-042791 |
| 2026-09-1111:30 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-26-042299 |
| 2026-09-0219:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-041213 |
| 2026-09-0120:05 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-26-041011 |
| 2026-08-2820:45 ET | 8-K | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-040622 |
| 2026-08-1721:03 ET | 8-K/A | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001493152-26-038786 |
| 2026-08-1320:30 ET | DEF 14A | Proxy statementPeriod 2026-08-13 | 0001493152-26-037821 |
| 2026-07-0123:27 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-031375 |
| 2026-06-1121:00 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-26-028301 |
| 2026-05-2713:00 ET | 8-K | 5.07 Shareholder vote results | 0001493152-26-025340 |
| 2026-05-1520:31 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001493152-26-023859 |
| 2026-05-0721:20 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-26-021767 |
| 2026-05-0113:23 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-020830 |
| 2026-04-2021:00 ET | DEF 14A | Proxy statementPeriod 2026-04-20 | 0001493152-26-018117 |
| 2026-03-3120:05 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001493152-26-014131 |
| 2026-03-1021:00 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-009551 |
| 2026-02-1722:20 ET | 8-K | 2.02 Results of operations | 0001493152-26-007204 |
| 2026-02-1122:03 ET | S-1/A | Registration statement, amended | 0001493152-26-006220 |
| 2026-02-1102:59 ET | S-1 | Registration statement | 0001493152-26-006073 |
| 2026-02-0222:20 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-004782 |
| 2026-01-1221:16 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-001861 |
| 2025-12-2921:05 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-25-029361 |
| 2025-12-1122:31 ET | S-1/A | Registration statement, amended | 0001493152-25-027310 |
| 2025-11-2822:31 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-25-025430 |
| 2025-11-2617:28 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-25-025082 |
| 2025-11-2121:05 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.05 Exit or disposal costs; 9.01 Financial statements and exhibits | 0001493152-25-024618 |
| 2025-11-1822:00 ET | S-1 | Registration statement | 0001493152-25-024089 |
| 2025-11-1721:05 ET | 8-K | 3.01 Delisting notice | 0001493152-25-023845 |
| 2025-11-1315:04 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001493152-25-022162 |
| 2025-11-0721:05 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-25-021256 |
| 2025-10-2120:05 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001493152-25-018788 |
| 2025-09-2221:00 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-25-014489 |
| 2025-09-1821:11 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-25-014097 |
| 2025-09-1720:26 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-25-013890 |
| 2025-09-0821:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001641172-25-026867 |
| 2025-09-0520:35 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001641172-25-026719 |
| 2025-08-1322:59 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001641172-25-023263 |
| 2025-08-0521:51 ET | S-1 | Registration statement | 0001641172-25-022101 |
| 2025-07-3021:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001641172-25-021566 |
| 2025-06-2513:22 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-016394 |
| 2025-05-2821:37 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001641172-25-012536 |
| 2025-05-1520:25 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001641172-25-010964 |
| 2025-05-0821:29 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001641172-25-009325 |
| 2025-05-0613:07 ET | DEF 14A | Proxy statementPeriod 2025-05-06 | 0001641172-25-008884 |
| 2025-04-2120:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-005553 |
| 2025-04-1020:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-003603 |
| 2025-04-0420:10 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001641172-25-002757 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.